Xyrem and D-ribose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xyrem (sodium oxybate) and D-ribose (ribose). Common drug interactions include chills among females and middle insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Xyrem and D-ribose. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Xyrem?

Xyrem has active ingredients of sodium oxybate. It is often used in narcolepsy. eHealthMe is studying from 81,487 Xyrem users. Check the latest studies of Xyrem.

What is D-ribose?

D-ribose has active ingredients of ribose. eHealthMe is studying from 109 D-ribose users. Check the latest studies of D-ribose.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

42 people who take Xyrem and D-ribose together, and have interactions are studied.

Xyrem and D-ribose drug interactions.

What are the common drug interactions of Xyrem and D-Ribose, by gender? *:

female:

  1. Chills (felling of cold)
  2. Disturbance in attention
  3. Drug administration error
  4. Feeling of body temperature change
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Tongue disorder (disease of tongue)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Upper respiratory tract infection
  9. Alopecia (absence of hair from areas of the body)
  10. Anxiety

male:

  1. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  2. Poor quality sleep
  3. Hypertension (high blood pressure)

What are the common drug interactions of Xyrem and D-Ribose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hypertension (high blood pressure)

30-39:

  1. Decreased appetite
  2. Discomfort
  3. Fatigue (feeling of tiredness)
  4. Nausea (feeling of having an urge to vomit)

40-49:

  1. Concussion (short loss of normal brain function in response to a head injury)
  2. Headache (pain in head)
  3. Migraine (headache)
  4. Nephrolithiasis (calculi in the kidneys)
  5. Drug ineffective
  6. Dry mouth
  7. Hypertension (high blood pressure)
  8. Visual impairment
  9. Anaphylactic reaction (serious allergic reaction)
  10. Blood pressure increased

50-59:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Weight increased
  3. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  4. Poor quality sleep
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Insomnia (sleeplessness)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Sedation
  9. Back pain
  10. Intervertebral disc protrusion (spinal disc protrusion)

60+:

  1. Bradycardia (abnormally slow heart action)
  2. Viral infection
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the existing conditions these people have? *

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 21.43%
  2. Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 14.29%
  3. Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 6 people, 14.29%
  4. Rosacea (a skin condition that causes facial redness): 3 people, 7.14%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Xyrem and D-ribose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xyrem and D-ribose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xyrem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of D-ribose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xyrem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between D-ribose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sodium oxybate and ribose (the active ingredients of Xyrem and D-ribose, respectively), and Xyrem and D-ribose (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: